Literature DB >> 26140534

A novel insulinotropic mechanism of whole grain-derived γ-oryzanol via the suppression of local dopamine D2 receptor signalling in mouse islet.

Chisayo Kozuka1, Sumito Sunagawa1, Rei Ueda1, Moritake Higa1,2, Yuzuru Ohshiro1,3, Hideaki Tanaka1,4, Chigusa Shimizu-Okabe5, Chitoshi Takayama5, Masayuki Matsushita6, Masato Tsutsui7, Shogo Ishiuchi8, Masanori Nakata9, Toshihiko Yada9, Jun-Ichi Miyazaki10, Seiichi Oyadomari11, Michio Shimabukuro12, Hiroaki Masuzaki1.   

Abstract

BACKGROUND AND
PURPOSE: γ-Oryzanol, derived from unrefined rice, attenuated the preference for dietary fat in mice, by decreasing hypothalamic endoplasmic reticulum stress. However, no peripheral mechanisms, whereby γ-oryzanol could ameliorate glucose dyshomeostasis were explored. Dopamine D2 receptor signalling locally attenuates insulin secretion in pancreatic islets, presumably via decreased levels of intracellular cAMP. We therefore hypothesized that γ-oryzanol would improve high-fat diet (HFD)-induced dysfunction of islets through the suppression of local D2 receptor signalling. EXPERIMENTAL APPROACH: Glucose metabolism and regulation of molecules involved in D2 receptor signalling in pancreatic islets were investigated in male C57BL/6J mice, fed HFD and treated with γ-oryzanol . In isolated murine islets and the beta cell line, MIN6 , the effects of γ-oryzanol on glucose-stimulated insulin secretion (GSIS) was analysed using siRNA for D2 receptors and a variety of compounds which alter D2 receptor signalling. KEY
RESULTS: In islets, γ-oryzanol enhanced GSIS via the activation of the cAMP/PKA pathway. Expression of molecules involved in D2 receptor signalling was increased in islets from HFD-fed mice, which were reciprocally decreased by γ-oryzanol. Experiments with siRNA for D2 receptors and D2 receptor ligands in vitro suggest that γ-oryzanol suppressed D2 receptor signalling and augmented GSIS. CONCLUSIONS AND IMPLICATIONS: γ-Oryzanol exhibited unique anti-diabetic properties. The unexpected effects of γ-oryzanol on D2 receptor signalling in islets may provide a novel; natural food-based, approach to anti-diabetic therapy.
© 2015 The British Pharmacological Society.

Entities:  

Year:  2015        PMID: 26140534      PMCID: PMC4562512          DOI: 10.1111/bph.13236

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  50 in total

Review 1.  Fatty acid receptors as new therapeutic targets for diabetes.

Authors:  Geetha Vani Rayasam; Vamshi Krishna Tulasi; Joseph Alex Davis; Vinay S Bansal
Journal:  Expert Opin Ther Targets       Date:  2007-05       Impact factor: 6.902

2.  Dopamine D2 receptors in addiction-like reward dysfunction and compulsive eating in obese rats.

Authors:  Paul M Johnson; Paul J Kenny
Journal:  Nat Neurosci       Date:  2010-03-28       Impact factor: 24.884

3.  Disruption of the dopamine d2 receptor impairs insulin secretion and causes glucose intolerance.

Authors:  Isabel García-Tornadú; Ana M Ornstein; Astrid Chamson-Reig; Michael B Wheeler; David J Hill; Edith Arany; Marcelo Rubinstein; Damasia Becu-Villalobos
Journal:  Endocrinology       Date:  2010-02-10       Impact factor: 4.736

4.  Afferent axons in abdominal vagus mediate satiety effect of cholecystokinin in rats.

Authors:  G P Smith; C Jerome; R Norgren
Journal:  Am J Physiol       Date:  1985-11

5.  High-fat diet decreases tyrosine hydroxylase mRNA expression irrespective of obesity susceptibility in mice.

Authors:  Yulin Li; Timothy South; Mei Han; Jiezhong Chen; Rui Wang; Xu-Feng Huang
Journal:  Brain Res       Date:  2009-03-11       Impact factor: 3.252

6.  Dopamine-mediated autocrine inhibitory circuit regulating human insulin secretion in vitro.

Authors:  Norman Simpson; Antonella Maffei; Matthew Freeby; Steven Burroughs; Zachary Freyberg; Jonathan Javitch; Rudolph L Leibel; Paul E Harris
Journal:  Mol Endocrinol       Date:  2012-08-21

7.  [Effects of gamma-oryzanol on the hypothalamo-pituitary axis in the rat].

Authors:  T Ieiri; N Kase; Y Hashigami; H Kobori; T Nakamura; S Shimoda
Journal:  Nihon Naibunpi Gakkai Zasshi       Date:  1982-10-20

8.  Brown rice and its component, γ-oryzanol, attenuate the preference for high-fat diet by decreasing hypothalamic endoplasmic reticulum stress in mice.

Authors:  Chisayo Kozuka; Kouichi Yabiku; Sumito Sunagawa; Rei Ueda; Shin-Ichiro Taira; Hiroyuki Ohshiro; Tomomi Ikema; Ken Yamakawa; Moritake Higa; Hideaki Tanaka; Chitoshi Takayama; Masayuki Matsushita; Seiichi Oyadomari; Michio Shimabukuro; Hiroaki Masuzaki
Journal:  Diabetes       Date:  2012-07-23       Impact factor: 9.461

9.  The Concise Guide to PHARMACOLOGY 2013/14: enzymes.

Authors:  Stephen P H Alexander; Helen E Benson; Elena Faccenda; Adam J Pawson; Joanna L Sharman; Michael Spedding; John A Peters; Anthony J Harmar
Journal:  Br J Pharmacol       Date:  2013-12       Impact factor: 8.739

10.  The IUPHAR/BPS Guide to PHARMACOLOGY: an expert-driven knowledgebase of drug targets and their ligands.

Authors:  Adam J Pawson; Joanna L Sharman; Helen E Benson; Elena Faccenda; Stephen P H Alexander; O Peter Buneman; Anthony P Davenport; John C McGrath; John A Peters; Christopher Southan; Michael Spedding; Wenyuan Yu; Anthony J Harmar
Journal:  Nucleic Acids Res       Date:  2013-11-14       Impact factor: 16.971

View more
  6 in total

1.  Syringol isolated from Eleusine coracana (L.) Gaertn bran suppresses inflammatory response through the down-regulation of cPLA2, COX-2, IκBα, p38 and MPO signaling in sPLA2 induced mice paw oedema.

Authors:  M D Milan Gowda; K Jayachandra; Vikram Joshi; Vaddarahally N Manjuprasanna; Gotravalli V Rudresha; Devadasan Velmurugan; Raman Pachaiappan; Noor Mohamed Jameel; Bannikuppe S Vishwanath
Journal:  Inflammopharmacology       Date:  2022-05-31       Impact factor: 5.093

2.  Marked augmentation of PLGA nanoparticle-induced metabolically beneficial impact of γ-oryzanol on fuel dyshomeostasis in genetically obese-diabetic ob/ob mice.

Authors:  Chisayo Kozuka; Chigusa Shimizu-Okabe; Chitoshi Takayama; Kaku Nakano; Hidetaka Morinaga; Ayano Kinjo; Kotaro Fukuda; Asuka Kamei; Akihito Yasuoka; Takashi Kondo; Keiko Abe; Kensuke Egashira; Hiroaki Masuzaki
Journal:  Drug Deliv       Date:  2017-11       Impact factor: 6.419

3.  Ninety-day oral toxicity study of rice-derived γ-oryzanol in Sprague-Dawley rats.

Authors:  Seol-Hee Moon; Duyeol Kim; Norihito Shimizu; Tadashi Okada; Shoketsu Hitoe; Hiroshi Shimoda
Journal:  Toxicol Rep       Date:  2016-12-06

4.  Impact of brown rice-specific γ-oryzanol on epigenetic modulation of dopamine D2 receptors in brain striatum in high-fat-diet-induced obesity in mice.

Authors:  Chisayo Kozuka; Tadashi Kaname; Chigusa Shimizu-Okabe; Chitoshi Takayama; Masato Tsutsui; Masayuki Matsushita; Keiko Abe; Hiroaki Masuzaki
Journal:  Diabetologia       Date:  2017-05-20       Impact factor: 10.122

5.  The Dietary Supplement γ-Oryzanol Attenuates Hepatic Ischemia Reperfusion Injury via Inhibiting Endoplasmic Reticulum Stress and HMGB1/NLRP3 Inflammasome.

Authors:  Yichao Du; Furui Zhong; Huanli Cheng; Tongxi Li; Yifan Chen; Peng Tan; Meizhou Huang; Tiancheng Liang; Yu Liu; Xianming Xia; Wenguang Fu
Journal:  Oxid Med Cell Longev       Date:  2021-09-02       Impact factor: 6.543

6.  Specific Expression of KCC2 in the α Cells of Normal and Type 1 Diabetes Model Mouse Pancreatic Islets.

Authors:  Chigusa Shimizu-Okabe; Shigeki Okada; Shiki Okamoto; Hiroaki Masuzaki; Chitoshi Takayama
Journal:  Acta Histochem Cytochem       Date:  2022-02-22       Impact factor: 1.938

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.